MedPath

BIOGENCY PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

TGA:26

Drug Approvals

Biogency Prostate Care (496533)

Product Name
Biogency Prostate Care
Approval Date
Jul 3, 2025
TGA

Biogency Synext (496137)

Product Name
Biogency Synext
Approval Date
Jul 2, 2025
TGA

Biogency Stress Relief (465037)

Product Name
Biogency Stress Relief
Approval Date
Oct 21, 2024
TGA

Biogency Synets (463071)

Product Name
Biogency Synets
Approval Date
Sep 30, 2024
TGA

Biogency Liver Detox (445720)

Product Name
Biogency Liver Detox
Approval Date
Apr 12, 2024
TGA

Biogency Synext (427918)

Product Name
Biogency Synext
Approval Date
Nov 15, 2023
TGA

Biogency B&E (423691)

Product Name
Biogency B&E
Approval Date
Oct 3, 2023
TGA

Biogency Growth Code (423690)

Product Name
Biogency Growth Code
Approval Date
Oct 3, 2023
TGA

Biogency B-Complex Chewable (420611)

Product Name
Biogency B-Complex Chewable
Approval Date
Aug 31, 2023
TGA

Biogency Vitamin C Chewable Tablets (419499)

Product Name
Biogency Vitamin C Chewable Tablets
Approval Date
Aug 23, 2023
TGA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.